Found: 18
Select item for more details and to access through your institution.
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.
- Published in:
- 2020
- By:
- Publication type:
- journal article
First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3307, doi. 10.3390/cancers16193307
- By:
- Publication type:
- Article
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1799, doi. 10.3390/cancers14071799
- By:
- Publication type:
- Article
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2639, doi. 10.3390/cancers13112639
- By:
- Publication type:
- Article
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1735, doi. 10.3390/cancers11111735
- By:
- Publication type:
- Article
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 896, doi. 10.3390/cancers11070896
- By:
- Publication type:
- Article
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 178, doi. 10.1111/ejh.13723
- By:
- Publication type:
- Article
Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
OAB-004: Carfilzomib-based induction/consolidation with or without autologous transplant and Lenalidomide (R) or Carfilzomib-Lenalidomide (KR) maintenance: efficacy in high-risk patients of the FORTE study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S3, doi. 10.1016/S2152-2650(21)02078-4
- By:
- Publication type:
- Article
LDH as Predictive Parameter in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S213, doi. 10.1016/j.clml.2018.07.075
- By:
- Publication type:
- Article
Heavy+Light Chain and Free Light Chain Assays at Baseline and During Follow-up in EMN02/HO95 Multiple Myeloma Clinical Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e47, doi. 10.1016/j.clml.2017.03.084
- By:
- Publication type:
- Article
Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e9, doi. 10.1016/j.clml.2017.03.015
- By:
- Publication type:
- Article
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1009, doi. 10.1002/hon.3035
- By:
- Publication type:
- Article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 995, doi. 10.1002/ajh.24463
- By:
- Publication type:
- Article
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 5, p. 564, doi. 10.1111/j.1365-2141.2011.08593.x
- By:
- Publication type:
- Article
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890376
- By:
- Publication type:
- Article
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9710, doi. 10.3390/curroncol30110705
- By:
- Publication type:
- Article